Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 866 of 1,261
  1. US 8471014

    Process of making gyrase and topoisomerase IV inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  2. US 8470837

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  3. WO 2013088335

    FORME CRISTALLINE DE CABAZITAXEL ET PROCÉDÉ POUR PRÉPARER CELLE-CI

    AVENTIS PHARMA SA [FR] · Granted Jun 20, 2013 · Expires Jun 15, 2033

    granted
  4. US 8466288

    Isoindolinone inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  5. US 8465917

    Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  6. US 8466290

    STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient

    Pharmadesign, Inc. · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  7. US 8465755

    Recombinant bacterium capable of eliciting an immune response against enteric pathogens

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  8. US 8466188

    Use of spiro-oxindole compounds as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  9. US 8466154

    Methods and compositions related to wrapping of dehydrons

    The Board of Regents of the University of Texas System · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  10. US 8466267

    Nucleic acid encoding a zinc finger that recognizes the sodium channel Nav 1.8 (PN3) gene

    Sangamo Biosciences, Inc. · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  11. US 8466276

    Oligomer conjugates of heteropentacyclic nucleosides

    Nektar Therapeutics · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  12. US 8466282

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  13. US 8465767

    Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles

    TAKEDA GMBH · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  14. US 8465746

    Compositions and methods for treatment, research and therapeutic applications for malaria

    Northwestern University · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  15. US 8465743

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  16. US 8465737

    Three-dimensional structure of complement receptor type 2 and uses thereof

    The Regents of the University of Colorado · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  17. US 8465749

    Polysaccharide-protein conjugate vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  18. US 8461345

    Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides)

    Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted
  19. US 8461348

    Heterocyclic derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted
  20. US 8461163

    Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1

    Takeda Pharmaceutical Company Limited · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted
  21. US 8461295

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Nektar Therapeutics · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted
  22. US 8461203

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted
  23. US 8461192

    Method of selectively inhibiting PKCiota

    The United States of America—Department of Veterans Affairs · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted
  24. US 8461172

    Solid forms and process for preparing

    Corcept Therapeutics Incorporated · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.